Background: Pertussis can cause severe disease in young infants before primary immunization. Classic inspiratory whoop may be absent, while apnea, cyanosis, and marked leukocytosis can dominate the presentation and lead to diagnostic diversion. We report a young infant with PCR-confirmed pertussis whose extreme leukocytosis initially raised concern for hematologic malignancy.
Case Presentation Summary: A 2-month-old boy presented with progressive paroxysmal cough associated with respiratory distress, apnea, facial flushing, and perioral cyanosis. His illness began with fever followed by dry cough that increased in frequency and severity. During an earlier hospitalization, he required supplemental oxygen up to 3 L/min and experienced two generalized seizure-like episodes lasting less than two minutes, suspected to represent hypoxic events associated with severe coughing episodes.
Leukocytosis exceeding 70,000/µL prompted referral to an oncology center for suspected hematologic malignancy; peripheral blood examination, however, showed no evidence of malignancy. Persistent paroxysmal cough with apnea and cyanosis raised suspicion for pertussis, subsequently confirmed by Bordetella pertussis PCR. Chest radiography demonstrated bilateral pulmonary opacities consistent with pneumonia. During subsequent hospitalization, the leukocyte count decreased to 30,100/µL. The infant had received hepatitis B vaccine but had not yet received a pertussis-containing vaccine. He received azithromycin for seven days, supplemental oxygen, and supportive care, with gradual clinical improvement.
Learning Points Discussion: In young infants, the absence of a classic whoop should not lower suspicion for pertussis when paroxysmal cough is accompanied by apnea, cyanosis, and marked leukocytosis. Extreme leukocytosis may mimic hematologic malignancy and divert the initial diagnostic pathway. Recognizing this constellation can facilitate timely molecular testing and appropriate management. The occurrence of severe disease before receipt of primary pertussis immunization also highlights the vulnerable period before vaccine-derived protection is established and reinforces the importance of strategies that protect infants during early life.

